How a new "breathalyzer" from the College of Veterinary Medicine could change the future of canine heart health.
The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
The FDA approved the first drug designed to delay congestive heart failure in dogs The medication targets dogs with early heart disease before symptoms develop Early treatment may improve lifespan and ...
DULUTH, Ga., Jan. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results